Thus, cryptic RNA accumulation due to TDP-43 dysfunction may have potential not only as a biomarker to stratify patients with and without TDP-43 pathology, but may also have important therapeutic implications for TDP-43 proteinopathies. Here, TARDBP is linked to proteostasis deficiencies.